Search the Newsreel

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power

Woodline Partners LP has reported a beneficial ownership of 8.1% in CalciMedica, Inc., totaling 2,489,729 shares of common stock. The investment firm, acting as an adviser to Woodline Master Fund LP, holds sole voting and dispositive power over these shares. This disclosure, made via …

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership stake of 6,364,000 shares in Treace Medical Concepts, Inc. (TMCI), representing 9.79% of the outstanding common stock. This ownership is held directly by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

T. Rowe Price (MEDP) discloses 7.2% Medpace Holdings stake in latest filing

T. Rowe Price Associates, Inc. has disclosed a 7.2% beneficial ownership stake in Medpace Holdings, Inc. (MEDP) through a SCHEDULE 13G filing. This represents 2,069,679 shares, with T. Rowe Price retaining sole voting power over 2,012,425 shares and sole dispositive power over all 2,069,679 …

Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 300,332 ordinary shares of IceCure Medical Ltd. (ICCM), representing 9.99% of the class, through a Schedule 13G SEC filing. These shares are held with shared voting and dispositive power. Armistice Capital acts as …

Why Medicenna Therapeutics Corp stock is skyrocketing today

T. Rowe Price Associates (KMTS) discloses 4.97M Kestra Medical shares in 13G/A

T. Rowe Price Associates, Inc. has disclosed a beneficial ownership of 4,968,900 shares of Kestra Medical Technologies common stock, representing 8.5% of the class as of June 30, 2026. The firm holds sole voting power over 4,966,936 shares and sole dispositive power over all …

Carl Zeiss Meditec Aktie: 3,8 Prozent auf 31,32 Euro

RBC Adjusts Price Target on CorMedix to $14 From $13, Maintains Outperform Speculative Risk Rating

RBC Capital Markets has increased its price target for CorMedix (CRMD) to $14 from $13, while reiterating an Outperform Speculative Risk rating. This adjustment reflects a positive outlook on the company's financial prospects and potential market performance.

CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains

CorMedix Therapeutics (CRMD) reported strong Q2 2026 results, with adjusted earnings and consolidated revenues surpassing analyst estimates, primarily driven by strong DefenCath sales and the contribution from the acquired Melinta portfolio. Following these positive results, management raised its full-year EBITDA outlook. The stock saw …

Armistice Capital discloses 9.53% CervoMed (CRVO) ownership via Master Fund

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 9.53% in CervoMed Inc. (CRVO), totaling 1,592,863 shares of common stock. These shares are held by Armistice Capital Master Fund Ltd., with Armistice Capital serving as the investment manager, granting them shared …

Earnings call transcript: PAVmed narrows Q2 2026 loss as shares slip

PAVmed Inc. (PAVM) reported a narrower GAAP net loss of $5.5 million, or $0.87 per share, in Q2 2026, down from $12.3 million a year earlier, driven by lower non-cash charges. Despite progress in its Lucid Diagnostics, Veris, PortIO, and Octeris programs, the stock …

Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance

Fresenius Medical Care stock is trading steadily around $23 in mid-August 2026, influenced by recent share buybacks and a modest year-to-date decline. The company's capital allocation strategy now includes renewed willingness for buybacks, alongside guidance for continued mid-single-digit revenue growth and improved operating income …

Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica

Armistice Capital, LLC and Steven Boyd have reported a significant holding in CalciMedica, Inc., disclosing beneficial ownership of 3,411,361 shares, which represents 9.99% of the company's common stock. The shares are directly held by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

New Ray Medicine Sets August Board Meeting to Review Interim Results and Dividend

SBC Medical Group's (SBC) Buy Rating Reiterated at BTIG Research

BTIG Research has reiterated its "Buy" rating for SBC Medical Group (NASDAQ: SBC) and set an $8.00 price target, representing a potential 150.78% upside. Despite this, analyst sentiment is mixed with an average "Hold" rating and an $8.50 target price from multiple analysts. The …

Townsquare Media (TSQ) stake of 824,004 shares disclosed in 13G/A

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have filed an amended 13G/A report disclosing a beneficial ownership of 824,004 shares of Townsquare Media (TSQ) Class A Common Stock, representing 4.9% of the class. The group …

Medicamen Biotech Q1 Results: Net profit up 54% YoY to ₹252.69 lakh

Tian An Medicare Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform

Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biological age as a core condition. CAMBRIDGE, Mass., Aug. 14, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", …

Zee Media Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Everest Medicines Reshapes Board With Director Resignation and New Appointment

CRMD News | CORMEDIX INC (NASDAQ:CRMD)

Medicamen Biotech consolidated net profit declines 1.40% in the June 2026 quarter

Q3 EPS Estimates for Journey Medical Cut by HC Wainwright

Research Analysts Offer Predictions for OBIO Q3 Earnings

Sambhaav Media shareholders approve FY26 accounts, reappoint Jagdish Pavra at AGM

Phoenix TV Narrows Loss as Revenue Jumps and Global Media Influence Grows

Kingworld Medicines Schedules Board Meeting to Review Interim Results and Dividend

Medical Properties Trust, Inc. (NYSE:MPT) Declares $0.09 Quarterly Dividend

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

PAVmed Inc. reported significant progress across its businesses, including Veris Health accelerating commercial engagement with OSU-The James and advancing its implantable physiological monitor towards FDA submission. Lucid Diagnostics secured its first laboratory benefit manager coverage policy for EsoGuard and recognized $1.5 million in revenue …

National CineMedia, Inc. (NASDAQ:NCMI) Just Reported, And Analysts Assigned A US$4.81 Price Target

National CineMedia, Inc. (NASDAQ:NCMI) recently reported its quarterly results, showing revenues in line with expectations but a significant increase in statutory losses. Analysts have maintained revenue forecasts but have expanded loss-per-share expectations, leading to an 8.3% dip in the average price target to US$4.81. …

MicroPort CardioFlow Medtech Sets Board Meeting to Approve Interim Results and Consider Dividend

Enterprise value to EBIT forward of K Wave Media, Ltd. – BOATS:KWMWW

This article provides financial data for K Wave Media, Ltd. (KWMWW), specifically focusing on its enterprise value to EBIT forward. It presents a value for a particular period, highlighting that this financial metric was "Made by humans." The data is presented within the context …

Liberty Media (FWONA): Wisconsin fund discloses 4.98% Formula One stake

The State of Wisconsin Investment Board has reported a 4.98% stake in Liberty Media Corp Series A Liberty Formula One Common Stock (FWONA), holding 1,195,287 shares. The fund maintains sole voting and dispositive power over these shares, indicating a passive investment just below the …

Trump Media (DJT) interim CEO uses 16,509 shares to cover tax withholding

Trump Media & Technology Group Corp.'s interim CEO, Kevin McGurn, reported a Form 4 transaction where he disposed of 16,509 shares of common stock. This disposition was solely to cover tax withholding payments by the company, not for personal cash proceeds. After the transaction, …

Sumitomo Mitsui Trust Group Inc. Acquires Shares of 534,803 Medical Properties Trust, Inc. $MPT